Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | HelsenDin.Org |
Description | HelsenDin.Org HelsenDin.Org New way to assess risk of breast cancer recurrence November 22, 2017 But new research from the Stanford University School of |
Keywords | N/A |
WebSite | helsendin.org |
Host IP | 5.104.110.217 |
Location | Germany |
Site | Rank |
US$1,470
Last updated: 2023-05-15 07:21:15
helsendin.org has Semrush global rank of 0. helsendin.org has an estimated worth of US$ 1,470, based on its estimated Ads revenue. helsendin.org receives approximately 169 unique visitors each day. Its web server is located in Germany, with IP address 5.104.110.217. According to SiteAdvisor, helsendin.org is safe to visit. |
Purchase/Sale Value | US$1,470 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$40 |
Yearly Ads Revenue | US$488 |
Daily Unique Visitors | 11 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
helsendin.org. | A | 3600 | IP: 5.104.110.217 |
helsendin.org. | NS | 3600 | NS Record: ns3.streamdns.net. |
helsendin.org. | NS | 3600 | NS Record: ns1.streamdns.net. |
helsendin.org. | NS | 3600 | NS Record: ns2.streamdns.net. |
helsendin.org. | MX | 3600 | MX Record: 20 mail.helsendin.org. |
helsendin.org. | MX | 3600 | MX Record: 10 mail.helsendin.org. |
helsendin.org. | TXT | 3600 | TXT Record: v=spf1 ip4:85.25.71.26 a mx ~all |
HelsenDin.Org HelsenDin.Org New way to assess risk of breast cancer recurrence November 22, 2017 But new research from the Stanford University School of Medicine suggests that looking at the immune cells in those lymph nodes - instead of the tumor cells - will yield a more accurate forecast. The finding could help clinicians determine which cancers to treat more aggressively to ensure the cancer goes away and doesn’t come back. "Immune changes in the lymph node almost perfectly predict clinical outcome, much better than any other prognostic factor that is available today," said Peter P. L... Recent evidence suggests caution in prescribing hormone therapy for breast cancer November 21, 2017 Because aromatase inhibitors reduce the rates of recurrence in women with early-stage postmenopausal breast cancer, these agents are not only becoming widely used in breast cancer treatment, but also being explored for their potential to prevent the disease in women at high risk. While focusing on |
HTTP/1.1 200 OK Server: nginx/1.20.2 Date: Sun, 26 Dec 2021 08:46:31 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive X-Powered-By: PHP/5.6.40 |
Domain Name: HELSENDIN.ORG Registry Domain ID: D170722487-LROR Registrar WHOIS Server: whois.iisp.com Registrar URL: whois.iisp.com Updated Date: 2021-12-27T08:49:55Z Creation Date: 2014-01-19T14:05:38Z Registry Expiry Date: 2023-01-19T14:05:38Z Registrar: NICENIC INTERNATIONAL GROUP CO., LIMITED Registrar IANA ID: 3765 Registrar Abuse Contact Email: support@nicenic.net Registrar Abuse Contact Phone: +86.7563366385 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: renewPeriod https://icann.org/epp#renewPeriod Registrant State/Province: Chelyabinsk Registrant Country: RU Name Server: NS1.STREAMDNS.NET Name Server: NS2.STREAMDNS.NET DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form https://www.icann.org/wicf/) >>> Last update of WHOIS database: 2021-12-29T19:17:43Z <<< |